LIPOLipella Pharmaceuticals Inc.

About Lipella Pharmaceuticals Inc. (LIPO)

Lipella Pharmaceuticals Inc. (LIPO) is a Biotechnology company headquartered in Pittsburgh, PA, United States whose shares trade over-the-counter on the Pink tier.

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications.

LIPO key facts

Ticker symbol

LIPO

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Pittsburgh, PA, United States

Country of incorporation

US

Year of incorporation

2005

Employees

6

Estimated market cap

$3.17M (as of Aug 1, 2025)

Shares outstanding

4,467,395

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Lipella Pharmaceuticals Inc. leadership

• Jonathan Kaufman — CEO
• Douglas Johnston — CFO
• Michael Chancellor — Chief Med. Officer

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with L